跳至主要内容
临床试验/NCT02143037
NCT02143037已完成不适用

CM Treatment for Alcohol Dependence Using New Technology

UConn Health4 个研究点 分布在 1 个国家目标入组 114 人开始时间: 2013年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
114
试验地点
4
主要终点
longest duration of actively attending treatment

研究概览

简要总结

Contingency management (CM) is highly efficacious for reducing substance use, and recent data suggest that reinforcing attendance at treatment can significantly improve treatment outcomes. Importantly, CM interventions that reinforce attendance are more likely to be adopted clinically than those that reinforce abstinence. Having objective indicators of drinking outcomes, nevertheless, is critical for quantifying the benefits of attendance-based CM treatment in alcohol abusing populations. New technology is now available to gauge alcohol use in patients' natural environments. The Secure Continuous Remote Alcohol Monitor (SCRAMx®) continuously monitors alcohol consumption 24 hours a day. As such, it may be ideal for objective evaluation of alcohol consumption during treatment intervention studies, including those that involve CM.

In this study, 114 patients participating in community based outpatient treatment programs for alcohol use disorders will wear SCRAMx for a 12-week period. They will be randomized to standard care or standard care plus CM, with reinforcement contingent upon attendance at treatment. The investigators will assess treatment attendance and alcohol use via SCRAMx and self reports. The investigators expect that patients randomized to the CM intervention will remain in treatment longer and show reductions in both SCRAMx assessed and self reported drinking days relative to those randomized to standard care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 18 years or older
  • current diagnosis of alcohol use disorder
  • able to pass an informed consent quiz
  • agree to wear a SCRAMx monitor for 12 weeks
  • have a standard, SCRAMx compatible phone line in their home or agree to attend the clinic at least every other week for data downloads
  • agree to sign an off-campus property transfer form and return SCRAMx equipment in 12 weeks

排除标准

  • serious, uncontrolled psychiatric illness
  • in recovery from pathological gambling
  • unstable address
  • intend to participate in activities incompatible with SCRAMx in the next 3 months
  • are wearing SCRAMx for legal purposes

研究组 & 干预措施

Control Group

Active Comparator

usual care

干预措施: usual care (Behavioral)

Experimental Group

Experimental

usual care plus prize contingency management for attending treatment

干预措施: prize contingency management for attending treatment (Behavioral)

Experimental Group

Experimental

usual care plus prize contingency management for attending treatment

干预措施: usual care (Behavioral)

结局指标

主要结局

longest duration of actively attending treatment

时间窗: 3 months

patient attendance to treatment groups as verified by clinic records (number of days attended out of number of days expected to treatment)

次要结局

未报告次要终点

研究者

发起方
UConn Health
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sheila Alessi

Associate Professor

UConn Health

研究点 (4)

Loading locations...

相似试验